JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

Search

Pfizer

Închisă

SectorSănătate

26.1 0.85

Rezumat

Modificarea prețului

24h

Curent

Minim

25.87

Maxim

26.22

Indicatori cheie

By Trading Economics

Venit

623M

3.6B

Vânzări

2B

17B

P/E

Medie Sector

15.047

90.422

EPS

0.87

Randament dividend

6.63

Marjă de profit

21.322

Angajați

81,000

EBITDA

325M

5.6B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+7.66% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

6.63%

2.13%

Următoarele câștiguri

3 feb. 2026

Data viitoare de dividende

6 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

6.9B

147B

Deschiderea anterioară

25.25

Închiderea anterioară

26.1

Sentimentul știrilor

By Acuity

35%

65%

102 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Pfizer Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

20 ian. 2026, 10:40 UTC

Achiziții, Fuziuni, Preluări

GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments -- Update

20 ian. 2026, 07:47 UTC

Achiziții, Fuziuni, Preluări

GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments

13 nov. 2025, 17:39 UTC

Achiziții, Fuziuni, Preluări

Pfizer Completes Acquisition of Metsera

10 nov. 2025, 13:08 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

10 nov. 2025, 09:41 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

20 ian. 2026, 07:13 UTC

Achiziții, Fuziuni, Preluări

GSK PLC: Agreement Simplifies ViiV's Shareholder Structure

20 ian. 2026, 07:13 UTC

Achiziții, Fuziuni, Preluări

GSK PLC to Get Special Div of $0.250B

20 ian. 2026, 00:21 UTC

Achiziții, Fuziuni, Preluări

Shionogi to Acquire Additional Shares in ViiV Healthcare for $2.1B

12 ian. 2026, 21:18 UTC

Market Talk

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

16 dec. 2025, 19:14 UTC

Câștiguri

These Stocks Are Moving the Most Today: Tesla, Pfizer, Humana, Circle, CoreWeave, Broadcom, IonQ, Ford, Navan, and More -- Barrons.com

16 dec. 2025, 17:08 UTC

Câștiguri

These Stocks Are Moving the Most Today: Tesla, Pfizer, Humana, Broadcom, IonQ, Ford, Navan, and More -- Barrons.com

16 dec. 2025, 17:05 UTC

Câștiguri

Pfizer CEO Defends Vaccines, Promises Growth by End of Decade -- Barrons.com

26 nov. 2025, 09:54 UTC

Acțiuni populare

Stocks to Watch Wednesday: Dell, HP, Workday -- WSJ

17 nov. 2025, 18:20 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

14 nov. 2025, 12:22 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Pharma Sector Becoming Bidding Battlefield -- Market Talk

13 nov. 2025, 16:26 UTC

Achiziții, Fuziuni, Preluări

Pfizer Completes Acquisition Of Metsera >PFE

10 nov. 2025, 16:35 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

10 nov. 2025, 16:26 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

10 nov. 2025, 15:36 UTC

Achiziții, Fuziuni, Preluări

What's Next for Novo Nordisk? -- WSJ

10 nov. 2025, 14:05 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

10 nov. 2025, 12:33 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov. 2025, 12:32 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:45 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:34 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:32 UTC

Acțiuni populare

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

10 nov. 2025, 09:26 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

8 nov. 2025, 13:10 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov. 2025, 03:50 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov. 2025, 03:41 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov. 2025, 03:07 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

Comparație

Modificare preț

Pfizer Așteptări

Obiectiv de preț

By TipRanks

7.66% sus

Prognoză pe 12 luni

Medie 28.53 USD  7.66%

Maxim 35 USD

Minim 25 USD

În baza a 17 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPfizer - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

17 ratings

5

Cumpărare

12

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

22.855 / 23.85Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

102 / 352 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat